Cointime

Download App
iOS & Android

Allogene Therapeutics

company
Exit Type
IPO
Exit Date
Oct 11, 2018

Exit parties in this round

Partner Fund Round Return Amount Return Multiplier
Pfizer Post-IPO Equity — — Detail
TPG Seed — — Detail
venBio Select Advisor Convertable Note — — Detail